marcus evans europe conferences

10th Annual Commercialisation of Regenerative Medicine

Guarantee Successful Commercialisation of Cell Therapies with Sustainable Production and Business Continuity

28-30 Nov 2012
Hilton London Kensington , United Kingdom

Key Topics

  • Understand the optimal business models for the future of regenerative medicines
  • Explore the new technologies in this fast growing field
  • Ensure you have the knowledge to mitigate the risks
  • Gain knowledge on funding and reimbursement strategies

    • Event Focus
     

    10th Annual Commercialisation of Regenerative Medicine

    Regenerative medicine has shown phenomenal potential to play a vital role in delivering the next generation of healthcare

    Regenerative medicine has shown phenomenal potential to play a vital role in delivering the next generation of healthcare. It offers treatments and possible cures for life threatening illnesses. Pharmaceutical companies are all eyeing on this new source of revenue with maturing technologies.

    -     What business models are regen med companies using?
    -     What are the key challenges for scaling up manufacturing production phases?
    -     What are the regulatory hurdles?

    This     marcus evans forum will answer these key questions to help delegates learn the best ways to further develop and commercialise their regenerative medicine products

     

    The Organisers

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.

    Sponsors
    Co Sponsor
    apceth GmbH & Co
    Visit website >>
    Event Partners

    • border=0


    Conference Speakers

    Chris Mason
    Professor of Regenerative Medicine
    UCL

    Robert J Sexauer
    Executive Vice President
    Intellicell Biosciences Inc

    Anthony Ting
    Director of Regenerative Medicine
    Athersys

    David Haddow
    Operations Director
    Altrika Ltd.

    Daya Lettvin
    Director, Investor Relations
    Pluristem

    Jim Faulkner
    Vice President, CMC & Supply
    GSK

    Joanna Miller
    Scientific Director
    Quy Biosciences Ltd t/a VetCell

    John Engels
    Vice President, Co-Founder
    AxoGen inc.

    Michael May
    Chief Executive Officer
    Centre for Commercialisation of Regenerative Medicine (CCRM)

    Michael Schuster
    Executive Vice President of Global Therapeutic Programs
    Mesoblast

    Jakub Shurek
    Chief Scientific Officer
    Primecell

    Charles Kessler
    Principle Scientific Officer
    European Commission

    Ralf Huss
    CSO
    Apceth

    Petter Bjorquist
    Head of Regenerative Medicine
    Cellectis Stem Cells

    Natalie Mount
    Chief Clinical Officer
    Cell Therapy Catapult, UK

    Francis Verhoeye
    Manufacturing Director
    Cardio3BioSciences S.A.

    Wilfried Dalemans
    Chief Technology Officer
    Tigenix

    Aidan Courtney
    Chief Executive Officer
    Roslin Cells Ltd.

    Social Networking
       
    Share





    General Enquiries

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Ola Samuelsson

    Regional Marketing Director - Europe & North America
    11 Connaught Place
    London, W2 2ET

    Telephone:     +44(0)20 3002 3276
    Fax: +44(0)20 3002 3016
    Email: olas@marcusevansuk.com